Drug intelligence / Profile preview

placebo + Boostrix

Development stage: Unknown
Lead developer: GSK
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

A clinical trial combination where Boostrix (a combined diphtheria, tetanus, acellular pertussis vaccine) is compared with placebo. Boostrix is a booster vaccine containing reduced amounts of diphtheria and tetanus toxoids combined with purified pertussis antigens. It's used for active booster immunization against tetanus, diphtheria, and pertussis in individuals aged 10 years and older, and for immunization during pregnancy to prevent pertussis in infants.

Beyond the preview

Go deeper on placebo + Boostrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on placebo + Boostrix.

Explore the full profile